Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other Working Capital Changes (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Other Working Capital Changes for 3 consecutive years, with -$3.6 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 162.64% to -$3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.1 million through Dec 2025, down 118.04% year-over-year, with the annual reading at -$2.1 million for FY2025, 118.04% down from the prior year.
  • Other Working Capital Changes hit -$3.6 million in Q4 2025 for Immunocore Holdings, down from $1.8 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $14.1 million in Q2 2023 to a low of -$18.1 million in Q1 2023.
  • Historically, Other Working Capital Changes has averaged $124500.0 across 3 years, with a median of $1.6 million in 2024.
  • Biggest five-year swings in Other Working Capital Changes: soared 153.23% in 2024 and later tumbled 162.64% in 2025.
  • Year by year, Other Working Capital Changes stood at -$10.7 million in 2023, then skyrocketed by 153.23% to $5.7 million in 2024, then plummeted by 162.64% to -$3.6 million in 2025.
  • Business Quant data shows Other Working Capital Changes for IMCR at -$3.6 million in Q4 2025, $1.8 million in Q3 2025, and -$1.1 million in Q2 2025.